NCT02189174View on ClinicalTrials.gov

Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 7, 2014

Primary Completion Date

November 12, 2015

Study Completion Date

November 12, 2015

Conditions
Advanced Solid Tumor
Interventions
DRUG

CLR457

Trial Locations (7)

10017

Memorial Sloan Kettering SC-4, New York

37203

Tennessee Oncology SC, Nashville

169610

Novartis Investigative Site, Singapore

02114

Massachusetts General Hospital SC-9, Boston

M5G 1X6

Novartis Investigative Site, Toronto

277 8577

Novartis Investigative Site, Kashiwa

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY